Chlorogenic acid prevents ovariectomized-induced bone loss by facilitating osteoblast functions and suppressing osteoclast formation

Aging (Albany NY). 2024 Mar 9;16(5):4832-4840. doi: 10.18632/aging.205635. Epub 2024 Mar 9.

Abstract

Osteoporosis is a usual bone disease in aging populations, principally in postmenopausal women. Anti-resorptive and anabolic drugs have been applied to prevent and cure osteoporosis and are associated to a different of adverse effects. Du-Zhong is usually applied in Traditional Chinese Medicine to strengthen bone, regulate bone metabolism, and treat osteoporosis. Chlorogenic acid is a major polyphenol in Du-Zhong. In the current study, chlorogenic acid was found to enhance osteoblast proliferation and differentiation. Chlorogenic acid also inhibits the RANKL-induced osteoclastogenesis. Notably, ovariectomy significantly decreased bone volume and mechanical properties in the ovariectomized (OVX) rats. Administration of chlorogenic acid antagonized OVX-induced bone loss. Taken together, chlorogenic acid seems to be a hopeful molecule for the development of novel anti-osteoporosis treatment.

Keywords: chlorogenic acid; osteoblast; osteoclast; osteoporosis; ovariectomized.

MeSH terms

  • Animals
  • Cell Differentiation
  • Chlorogenic Acid / metabolism
  • Chlorogenic Acid / pharmacology
  • Chlorogenic Acid / therapeutic use
  • Female
  • Humans
  • Osteoblasts / metabolism
  • Osteoclasts*
  • Osteogenesis
  • Osteoporosis* / metabolism
  • Rats

Substances

  • Chlorogenic Acid